Loading...

Home
Stock
CMRX

CMRX News & Events

-

$

0.000

0.000(0.000%)1D

Overview Forecast Valuation Earnings News

Loading...

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Select market data provided by Financial Markets Infrastructure and Data|LSEG

Broker connection service provided by Connect to brokerage accounts for data and trading SnapTrade

Company

Home
Contact
About Us
News Release

Market

Market Analysis
Crypto
Market Movers
Stock Monitor
All US Stocks

Strategies

AI Stock Picker
Swing Trading
QuantAI Alpha Pick
CoinSwing
Daytrading Radar
Crypto Radar
Char Pattern Detection

Resource

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat with Tia
AI Screener
Backtesting Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Option Profit Calculator

Features

AI Stock Picker
Swing Trading
QuantAI Alpha Pick
Whales Auto Tracker
Daytrading Center
Patterns Detection
Financial AI Agent
AI Screener
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Stock Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Monitor News

Compare

TradingView
Seeking Alpha

CMRX News

Top 3 Health Care Stocks That May Crash In Q2

Apr 07 2025Benzinga

Chimerix GAAP EPS of -$0.25 beats by $0.01, revenue of $0.06M misses by $0.25M

Mar 21 2025SeekingAlpha

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, CMRX, WBA, CKPT on Behalf of Shareholders

Mar 17 2025PRnewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RDFN, BLBX, CMRX, WBA on Behalf of Shareholders

Mar 12 2025Globenewswire

Kuehn Law Encourages BRDG, CMRX, WBA and SYTA Investors to Contact Law Firm

Mar 11 2025PRnewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 2seventy bio, Inc. (Nasdaq - TSVT), Bridge Investment Group Holdings Inc. (NYSE - BRDG), Chimerix, Inc. (Nasdaq - CMRX), 180 Degree Capital Corp. (Nasdaq – TURN)

Mar 11 2025Globenewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, CMRX, WBA on Behalf of Shareholders

Mar 11 2025Globenewswire

CHIMERIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Chimerix, Inc. - CMRX

Mar 11 2025Businesswire

CMRX Events

Chimerix reports Q4 EPS (25c), consensus (28c)

Reports Q4 revenue $57,000, consensus $310,600. "The recent FDA acceptance of the dordaviprone NDA marks an important milestone for Chimerix and offers renewed hope for patients diagnosed with this life-threatening cancer," said Mike Andriole, Chief Executive Officer of Chimerix. "Our mission to bring dordaviprone to patients globally is greatly enhanced by the pending acquisition of Chimerix by Jazz. We continue to prepare to bring dordaviprone to patients in need as quickly as possible."

CMRX Monitor News

an image of No data

No data

CMRX Earnings Analysis

an image of undefined

People Also Watch